secwatch.observer — SEC 8-K summary
======================================

Issuer:     Disc Medicine, Inc. (IRON)
CIK:        0001816736
Form:       8-K
Filed at:   2023-06-09T23:59:59+00:00
Accession:  0001193125-23-164532
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Disc Medicine shareholders elect directors, ratify auditor at 2023 annual meeting
--------------------------------------------------------------------------------

- Elected Georges Gemayel, Mark Chin, and Liam Ratcliffe as Class II directors for two-year term ending 2025.
- Elected Donald Nicholson, William White, and John Quisel as Class III directors for three-year term ending 2026.
- Ratified Ernst & Young as independent auditor for fiscal year ending December 31, 2023.
- All director nominees received substantial majority of votes cast; broker non-votes ~980k.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1816736/000119312523164532/0001193125-23-164532-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1816736/000119312523164532/d477797d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-164532

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer